Filgrastim in patients with neutropenia: potential effects on quality of life.

@article{Lyman2002FilgrastimIP,
  title={Filgrastim in patients with neutropenia: potential effects on quality of life.},
  author={Gary H. Lyman and Nicole M. Kuderer},
  journal={Drugs},
  year={2002},
  volume={62 Suppl 1},
  pages={65-78}
}
Treatment- and disease-related neutropenia are associated with a number of negative clinical effects such as febrile neutropenia, documented infection, hospitalisation for infection-related morbidity, infection-related mortality, and decreased ability to administer the planned chemotherapy dose on schedule. Reductions or delays in dosage have the ability to… CONTINUE READING